Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is a lead cause of dementia in approximately 5.8 million Americans. Further, it is estimated that the number will soar to 13.5 million by 2050.
Owing to the R&D done in understanding Alzheimer’s disease so far, it has been clear that there is an abnormally massive build-up of protein fragment beta-amyloid (called beta-amyloid plaques) outside neurons and tau protein (called tau tangles) inside neurons, which are a core reason behind the inference between neuron-to-neuron communication at synapses and blocking of the transportation of nutrients and other essential molecules inside the...
